Spanda advances in stages, each de-risking the next. Three are already done and reproducible; the decisive experiment is now one bench run away. Here is the whole path, honestly placed.
Drug discovery, strain design, and basic biology still run on wet-lab cycles measured in months and millions. A whole-cell simulator you could actually believe — one that can't violate the second law, that you can perturb and query in silico — would compress those cycles the way computational fluid dynamics compressed the wind tunnel. Spanda's bet is that thermodynamic consistency is the missing foundation: get the physics exactly right at the smallest scale, and the biology becomes predictive. We start with the minimal cell because it is the one place this is tractable today — and build outward.
Thermodynamic engine with 258+ tests; 13-reaction emergent-autonomy proof; 2,069-reaction syn3A model with conservation verified at every event.
Detailed-balance audit of syn3A, E. coli iML1515 and Yeast-GEM v9 — 7,181 reactions at structural tier — establishing a universal 13–17% direction-reversal rate, significant vs null.
Emergent metabolic bistability and a ~105-min cell cycle from first principles, alongside the cross-domain universality arm — life-like behaviour from the invariant alone.
Extending the audit to more organisms and datasets, and the engine toward spatial, real-time simulation — hardening the result before it meets the bench.
Test the lactate prediction by metabolomics with a design-partner lab — the single experiment that de-risks the entire thesis.
Scale toward GPU-resident, spatial, real-time whole-cell simulation — a virtual cell you can perturb, simulate and query across organisms.
Everything before validation is built and reproducible. Crossing the bench is what turns a strong computational case into an undeniable one — and that is exactly where support compounds.